Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 (ASPECT-2) Research Group. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial - Van Es, RF; Jonker, JJ; Verheught, FW (Lancet, 2002)
et al.